BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 16509766)

  • 1. Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease.
    Zeisberg M; Khurana M; Rao VH; Cosgrove D; Rougier JP; Werner MC; Shield CF; Werb Z; Kalluri R
    PLoS Med; 2006 Apr; 3(4):e100. PubMed ID: 16509766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of MMP-2, MMP-9 (type IV collagenases/gelatinases), and MT1-MMP in canine X-linked Alport syndrome (XLAS).
    Rao VH; Lees GE; Kashtan CE; Nemori R; Singh RK; Meehan DT; Rodgers K; Berridge BR; Bhattacharya G; Cosgrove D
    Kidney Int; 2003 May; 63(5):1736-48. PubMed ID: 12675849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laminin compensation in collagen alpha3(IV) knockout (Alport) glomeruli contributes to permeability defects.
    Abrahamson DR; Isom K; Roach E; Stroganova L; Zelenchuk A; Miner JH; St John PL
    J Am Soc Nephrol; 2007 Sep; 18(9):2465-72. PubMed ID: 17699809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of alpha3/alpha4(IV) collagen from the glomerular basement membrane induces a strain-dependent isoform switch to alpha5alpha6(IV) collagen associated with longer renal survival in Col4a3-/- Alport mice.
    Kang JS; Wang XP; Miner JH; Morello R; Sado Y; Abrahamson DR; Borza DB
    J Am Soc Nephrol; 2006 Jul; 17(7):1962-9. PubMed ID: 16769745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laminin-1 reexpression in Alport mouse glomerular basement membranes.
    Abrahamson DR; Prettyman AC; Robert B; St John PL
    Kidney Int; 2003 Mar; 63(3):826-34. PubMed ID: 12631063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagen receptors integrin alpha2beta1 and discoidin domain receptor 1 regulate maturation of the glomerular basement membrane and loss of integrin alpha2beta1 delays kidney fibrosis in COL4A3 knockout mice.
    Rubel D; Frese J; Martin M; Leibnitz A; Girgert R; Miosge N; Eckes B; Müller GA; Gross O
    Matrix Biol; 2014 Feb; 34():13-21. PubMed ID: 24480069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A human-mouse chimera of the alpha3alpha4alpha5(IV) collagen protomer rescues the renal phenotype in Col4a3-/- Alport mice.
    Heidet L; Borza DB; Jouin M; Sich M; Mattei MG; Sado Y; Hudson BG; Hastie N; Antignac C; Gubler MC
    Am J Pathol; 2003 Oct; 163(4):1633-44. PubMed ID: 14507670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial cell-specific collagen type IV-α
    Funk SD; Bayer RH; Miner JH
    Am J Physiol Renal Physiol; 2019 May; 316(5):F830-F837. PubMed ID: 30724107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulated expression of integrin α1 in mesangial cells and integrin α3 and vimentin in podocytes of Col4a3-null (Alport) mice.
    Steenhard BM; Vanacore R; Friedman D; Zelenchuk A; Stroganova L; Isom K; St John PL; Hudson BG; Abrahamson DR
    PLoS One; 2012; 7(12):e50745. PubMed ID: 23236390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomechanical strain causes maladaptive gene regulation, contributing to Alport glomerular disease.
    Meehan DT; Delimont D; Cheung L; Zallocchi M; Sansom SC; Holzclaw JD; Rao V; Cosgrove D
    Kidney Int; 2009 Nov; 76(9):968-76. PubMed ID: 19710627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocytes are dispensable for glomerulonephritis but required for renal interstitial fibrosis in matrix defect-induced Alport renal disease.
    Lebleu VS; Sugimoto H; Miller CA; Gattone VH; Kalluri R
    Lab Invest; 2008 Mar; 88(3):284-92. PubMed ID: 18180701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A unique evolution of the kidney phenotype in a patient with autosomal recessive Alport syndrome.
    Vischini G; Kapp ME; Wheeler FC; Hopp L; Fogo AB
    Hum Pathol; 2018 Nov; 81():229-234. PubMed ID: 29530752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of collagen type IV genes is organ-specific: evidence from a canine model of Alport syndrome.
    Zheng K; Perry J; Harvey SJ; Sado Y; Ninomiya Y; Jefferson B; Jacobs R; Hudson BG; Thorner PS
    Kidney Int; 2005 Nov; 68(5):2121-30. PubMed ID: 16221211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome.
    Gross O; Beirowski B; Koepke ML; Kuck J; Reiner M; Addicks K; Smyth N; Schulze-Lohoff E; Weber M
    Kidney Int; 2003 Feb; 63(2):438-46. PubMed ID: 12631109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-Linked Alport Dogs Demonstrate Mesangial Filopodial Invasion of the Capillary Tuft as an Early Event in Glomerular Damage.
    Clark SD; Nabity MB; Cianciolo RE; Dufek B; Cosgrove D
    PLoS One; 2016; 11(12):e0168343. PubMed ID: 27959966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of assembly of recombinant type IV collagen alpha3, alpha4, and alpha5 chains in transfected cell strains.
    Kobayashi T; Uchiyama M
    Kidney Int; 2003 Dec; 64(6):1986-96. PubMed ID: 14633121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alport syndrome: Hereditary nephropathy associated with mutations in genes coding for type IV collagen chains].
    Heidet L; Gubler MC
    Nephrol Ther; 2016 Dec; 12(7):544-551. PubMed ID: 27816395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of type IV collagen subchains in the glomerular basement membrane of patients with Alport syndrome with confocal microscopy.
    Su J; Liu ZH; Zeng CH; Wei-Gong ; Chen HP; Li LS
    Nephrol Dial Transplant; 2006 Jul; 21(7):1838-47. PubMed ID: 16574687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of glomerular type IV collagen alpha3-5 chain expression in children with thin basement membrane disease.
    Ueda T; Nakajima M; Akazawa H; Maruhashi Y; Shimoyama H; Sakagami Y; Takagawa K; Kamitsuji H; Naito I; Sado Y; Yoshioka A
    Nephron; 2002 Oct; 92(2):271-8. PubMed ID: 12218303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative trait loci influence renal disease progression in a mouse model of Alport syndrome.
    Andrews KL; Mudd JL; Li C; Miner JH
    Am J Pathol; 2002 Feb; 160(2):721-30. PubMed ID: 11839593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.